Pay in 4 interest-free payments of $80.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
targeting the CD27 axis was shown to be feasible and safe in early clinical trials with the most commonly occurring side effects being thrombocytopenia
Species Human Accession P10145 Amino Acid Sequence SAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENSGGGGSHHHHHHHHHH
Angela F Messmer-Blust（2011）Trends Cardiovasc Med
Expression System HEK293 Molecular Weight 26-28kDa Purity ＞95% by SDS-PAGE Endotoxin <0
The following factors were formulated with diluent (1 ×) at a concentration of 50 ng/mL to detect cross-reactivity with Human IL-1β
MFI2/CD228 His Tag Protein, Human Fc receptor targeting the CD27 axis wasProduct Specification Species Human Accession P08582 Amino Acid Sequence Gly20 Cys709, with C terminal 8*His